4.0
May 17, 2026
Former employee, more than 10 years
Boston, MA
Recommend
CEO approval
Business Outlook
Pros
Good company benefits. Strong leadership in Oncology Account Group segment. Pipeline from 2029 and beyond looks strong. The Oncology Key Account Role offers a lot of diverse experiences and is an asset to the teams
Cons
Does not pay at high level in comparison to other smaller companies in sales/ commercial side.